Cure8 research brief
This study suggests that older-onset IBD is managed more conservatively and experiences fewer extraintestinal manifestations. Patients and clinicians should be aware that age can influence treatment choices and that age-specific guidance may be needed.
Older adult IBD patients and their caregivers, gastroenterologists and IBD clinicians, and researchers studying age-related differences in IBD management.
This is a single retrospective cohort study of 1,245 adult IBD patients (56 with disease onset at ≥60 years) comparing demographics, disease features, and treatment patterns between older- and younger-onset groups.
Key findings reported in the abstract: older-onset disease was more often ulcerative colitis, had fewer extraintestinal manifestations, and used immunosuppressive and biologic therapies less frequently.
Clinical context The study highlights potential undertreatment of older-onset IBD due to safety concerns, and the authors call for research and guidelines tailored to older patients to balance risks and long-term outcomes.
This report is a retrospective cohort from a single center/time span (1993–2023) summarized in the article abstract. Findings describe treatment patterns and associations but do not establish causality; individual treatment decisions consider comorbidities and risks not detailed here.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Patients, families, and clinicians may care because the study shows pediatric-onset IBD is more often Crohn's and that children begin advanced therapies earlier than adults. The adult persistence data for vedolizumab and...
The study suggests a possible link between psoriasis, leaky gut, and Crohn’s disease—topics that could help explain why some people with psoriasis report more gut problems. People with psoriasis or IBD may find the...
The review brings together evidence that genetics, immune responses, the gut microbiome, and environmental triggers interact to cause Crohn's disease and ulcerative colitis.
